Antibody-dependent cellular cytotoxicity to human colon-tumour cells. II. Analysis of the antigens involved
Open Access
- 1 August 1979
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 40 (2) , 244-252
- https://doi.org/10.1038/bjc.1979.172
Abstract
The relationship between carcinoembryonic antigen (CEA) and A antigenic determinants on the cell surface of colon-tumour cells was studied by the ADCC assay. Antiserum prepared in 2 rabbits to an undecapeptide analogous to the amino terminal of CEA(1-11) was found by us either to participate in (Rabbit 2) or specifically inhibit (Rabbit 1) ADCC. The binding spectra of these two antisera and of antiserum to the whole CEA molecule were similar. All of them react with A and non-A colon-tumour cells as well as red blood cells of Type A (RBC-A) and their activity was completely absorbed on RBC-A but not on B or O. O-type, ADCC-reactive human sera always react with A-type colon-tumour cells and RBC-A, and some of them with non-A colon-tumour cells also. The degree of inhibition of their reactivity by anti-CEA(1-11) R1 varied between sera, from none to almost a complete inhibition, and is not related to whether the serum is of cancer or non-cancer origin. Non-reactive O-type sera contain anti-A activity demonstrable by haemagglutination and immunofluorescence. However, they cannot participate in ADCC reaction nor inhibit it. The sera, which contain lymphocyte-dependent antibody to A-type colon-tumour cells, lysed RBC-A, without the addition of lymphocytes or complement, in an immunologically specific way. It is concluded that the reactivity seen in our ADCC system is related to a determinant common to A and CEA (and maybe to other normal cross-reacting antigens) which most probably resides in the amino terminal part of these molecules. This determinant elicits the production of lymphocyte-dependent antibodies in about 50% of people with blood group O. Thus, the amino terminal part of CEA is not a tumour-specific part of the CEA molecule. No specific anti-tumour activity was found in patients' serum by this method, and claims for its demonstration by other methods may well be related to the non-specific activity observed here.Keywords
This publication has 11 references indexed in Scilit:
- Antibody-dependent cellular cytotoxicity to human colon-tumour cells. I. Lack of tumour specificity in a population studyBritish Journal of Cancer, 1979
- Immunological cross-reactivity of antibodies to a synthetic undecapeptide analogous to the amino terminal segment of carcinoembryonic antigen, with the intact protein and with human sera.Proceedings of the National Academy of Sciences, 1976
- Carcinoembryonic antigen (CEA): Molecular biology and clinical significanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1975
- A NEW SENSITIVE ASSAY FOR ANTIBODY AGAINST CELL SURFACE ANTIGENS BASED ON INHIBITION OF CELL-DEPENDENT ANTIBODY-MEDIATED CYTOTOXICITYThe Journal of Experimental Medicine, 1974
- The blood group A-like site on the carcinoembryonic antigen.1973
- Substances immunologically related to CEA.1973
- Characterization of the antibody-dependent cytotoxic cell. A non-phagocytic monocyte?1973
- Carcinoembryonic Antigen-Antibody Complexes in a Patient with Colonic Carcinoma and Nephrotic SyndromeNew England Journal of Medicine, 1973
- Absence of circulating antibodies to carcinoembryonic antigen in patients with gastrointestinal malignanciesInternational Journal of Cancer, 1972
- Competition for receptors for immunoglobulin on cytotoxic lymphocytes.1972